Suvanza Pharma, LLC (SUVZ)
Suvanza Pharma, LLC operates in the Biotechnology industry of the Healthcare sector, headquartered in Miami Beach, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1.0M. Its beta of 0.59 implies it has historically moved less than the broad market.
Suvanza Pharma, LLC is an emerging biotechnology enterprise dedicated to developing RapiDerm, an innovative drug delivery system applied to the skin, specifically targeting dermatological disorders. The company, which began operations in 2004 and is headquartered in Miami Beach, Florida, officially changed its name from Hamilton PNG to Suvanza Pharma, LLC in March 2010.
Suvanza Pharma, LLC is most often compared with the following Healthcare names: